ORTI-B Ortivus AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · ortivus.com

1.535SEK+0.99%Mkt Cap: 13.01M $P/E: —Today

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and EC…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap13.01M USD

Enterprise Value15.17M USD

Revenue (TTM)7.31M USD

Gross Profit2.83M USD

Net Income (TTM)-2.09M USD

Revenue/Share1.04 SEK

Last Price1.535 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees32

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG0.50

EV/EBITDA-8.70

EV/Revenue2.08

P/S1.76

P/B6.01

EPS (TTM)-0.29

EPS (Forward)—

52W Range

0.802055% of range2.140

52W High2.140 SEK

52W Low0.8020 SEK

Profitability

Gross Margin40.33%

Oper. Margin-31.77%

EBITDA Margin-23.87%

Profit Margin-29.80%

ROE-97.60%

ROA-30.84%

Growth

Revenue Growth-1.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.41M USD

CapEx (TTM)917.59K USD

FCF Margin-34.29%

FCF Yield-19.26%

Net Debt2.29M USD

Net Debt/EBITDA-1.31

Balance Sheet

Debt/Equity0.87

Current Ratio1.08

Quick Ratio0.73

Book Value/Sh0.25 SEK

Cash/Share0.08 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.86.95M

Float9.15M

Insiders72.27%

Institutions11.34%

Technical

SMA 501.817 (-15.5%)

SMA 2001.669 (-8.0%)

Beta0.90

S&P 52W Chg14.58%

Avg Vol (30d)10.33K

Avg Vol (10d)14.60K

Technical Indicators

RSI (14)36.7

MACD-0.0842

MACD Signal-0.0632

MACD Hist.-0.0210

BB Upper2.067 SEK

BB Middle1.724 SEK

BB Lower1.382 SEK

BB Width39.72%

ATR (14)0.1758 SEK

Vol Ratio (20d)5.61x